DE69737088D1 - Therapeutisches agens zur behandlung von fiv infektionen - Google Patents

Therapeutisches agens zur behandlung von fiv infektionen

Info

Publication number
DE69737088D1
DE69737088D1 DE69737088T DE69737088T DE69737088D1 DE 69737088 D1 DE69737088 D1 DE 69737088D1 DE 69737088 T DE69737088 T DE 69737088T DE 69737088 T DE69737088 T DE 69737088T DE 69737088 D1 DE69737088 D1 DE 69737088D1
Authority
DE
Germany
Prior art keywords
treatment
therapeutic agent
fiv infections
fiv
infections
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69737088T
Other languages
English (en)
Other versions
DE69737088T2 (de
Inventor
Tsunesuke Kajimoto
Makoto Suzuki
Ryougai Go
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Toray Industries Inc
Original Assignee
Toray Industries Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toray Industries Inc filed Critical Toray Industries Inc
Application granted granted Critical
Publication of DE69737088D1 publication Critical patent/DE69737088D1/de
Publication of DE69737088T2 publication Critical patent/DE69737088T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
DE69737088T 1996-10-31 1997-10-30 Therapeutisches agens zur behandlung von fiv infektionen Expired - Lifetime DE69737088T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP29060196 1996-10-31
JP29060196A JP3845915B2 (ja) 1996-10-31 1996-10-31 ネコのアトピー性皮膚炎治療剤および治療方法
PCT/JP1997/003963 WO1998018484A1 (fr) 1996-10-31 1997-10-30 Agent therapeutique et therapie diriges contre les infections par le virus du sida felin et contre la dermatite atopique feline

Publications (2)

Publication Number Publication Date
DE69737088D1 true DE69737088D1 (de) 2007-01-25
DE69737088T2 DE69737088T2 (de) 2007-04-12

Family

ID=17758124

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69739332T Expired - Lifetime DE69739332D1 (de) 1996-10-31 1997-10-30 Felines Interferon gegen Feline atopische Dermatitis
DE69737088T Expired - Lifetime DE69737088T2 (de) 1996-10-31 1997-10-30 Therapeutisches agens zur behandlung von fiv infektionen

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE69739332T Expired - Lifetime DE69739332D1 (de) 1996-10-31 1997-10-30 Felines Interferon gegen Feline atopische Dermatitis

Country Status (8)

Country Link
US (1) US6194381B1 (de)
EP (2) EP0875251B1 (de)
JP (1) JP3845915B2 (de)
CA (2) CA2241941C (de)
DE (2) DE69739332D1 (de)
ES (2) ES2323326T3 (de)
PT (2) PT1743650E (de)
WO (1) WO1998018484A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE40374E1 (en) 1998-05-29 2008-06-10 Heska Corporation Canine IL-13 immunoregulatory proteins and uses thereof
WO1999061618A2 (en) 1998-05-29 1999-12-02 Heska Corporation Canine and feline immunoregulatory proteins, nucleic acid molecules, and uses thereof
US20020127200A1 (en) 1998-05-29 2002-09-12 Shumin Yang Canine and feline immunoregulatory proteins, nucleic acid molecules, and uses thereof
US6482403B1 (en) 1998-05-29 2002-11-19 Heska Corporation Caniney IL-13 immunoregulatory proteins and uses thereof
IL155741A0 (en) * 2000-11-03 2003-12-23 Pbl Biomedical Lab Interferons, uses and compositions related thereto

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE120798T1 (de) * 1987-12-29 1995-04-15 Toray Industries Synthetisches plasmid, transformierte zelle, katzen-interferon-gen und verfahren zur herstellung von katzen-interferon.
JP2982177B2 (ja) * 1989-06-14 1999-11-22 東レ株式会社 発現プラスミド、形質転換酵母および該酵母を用いたネコインターフェロンの製造法
CA2019803C (en) * 1989-06-29 2000-04-25 Akira Yanai Feline interferon and process for production thereof
JP3640980B2 (ja) * 1993-04-09 2005-04-20 株式会社林原生物化学研究所 ネコの呼吸器疾患治療剤とその治療剤を用いる治療方法
JP3269125B2 (ja) * 1994-01-28 2002-03-25 東レ株式会社 アトピー性皮膚炎治療薬
GB9414752D0 (en) * 1994-07-21 1994-09-07 Q One Biotech Ltd Feline gamma-interferon
JPH0940580A (ja) * 1995-07-28 1997-02-10 Boehringer Ingelheim Internatl Gmbh 抗ＨＩＶ剤ＩＦＮ−ω

Also Published As

Publication number Publication date
EP1743650A3 (de) 2007-03-21
US6194381B1 (en) 2001-02-27
EP0875251B1 (de) 2006-12-13
JPH10130165A (ja) 1998-05-19
EP0875251A4 (de) 2004-04-21
JP3845915B2 (ja) 2006-11-15
DE69737088T2 (de) 2007-04-12
WO1998018484A1 (fr) 1998-05-07
ES2275283T3 (es) 2007-06-01
EP0875251A1 (de) 1998-11-04
EP1743650B1 (de) 2009-03-25
CA2638985C (en) 2011-11-29
ES2323326T3 (es) 2009-07-13
CA2241941C (en) 2008-11-18
PT1743650E (pt) 2009-06-25
DE69739332D1 (de) 2009-05-07
PT875251E (pt) 2007-01-31
EP1743650A2 (de) 2007-01-17
CA2638985A1 (en) 1998-05-07
CA2241941A1 (en) 1998-05-07

Similar Documents

Publication Publication Date Title
DE122009000012I1 (de) Substituierte pyrazolyl-benzolsulfonamide zur behandlung von entzundungen.
ATE235481T1 (de) Substituierte benzopyranderivate zur behandlung von entzündungen
ATE251903T1 (de) Verwendung von phosphororganischen verbindungen zur therapeutischen und prophylaktischen behandlung von infektionen
DE60023128D1 (de) Pyrazolecarboxamide zur behandlung von fettleibigkeit und anderen erkrankungen
DE69412552D1 (de) Medizinisches Instrument zur Behandlung von Sinusitis
DE69612465D1 (de) Verwendung von Rifamyciderivaten zur Behandlung von Chlamydia-Infektionen
DE69729817D1 (de) Behandlung von Aldehyd-fixierten Geweben
DE69620691D1 (de) Therapeutisches Mittel zur Behandlung der Hypercholesterinämie
ID21948A (id) Penggunaan 1-hidroksi-2piridon untuk pengobatan infeksi-infeksi kulit
DE69737067D1 (de) Vakzine zur behandlung von mycosen
DE69807466T2 (de) Triptolid-derivate nützlich zur behandlung von autoimmunkrankheiten
DE69420229T2 (de) Pharmazeutische Zusammensetzung zur Behandlung von AIDS
DE69829217D1 (de) Vorrichtung zur therapeutischen behandlung von blutgefässen
ATE226071T1 (de) Antikonvulsive derivate zur behandlung von neuropathischem schmerz
ID21874A (id) Penggunaan 1-hidroksi-2-piridon untuk pengobatan infeksi urap kulit
DE69822297D1 (de) Triptolid-derivate geeignet zur behandlung von autoimmunkrankheiten
ATE253578T1 (de) Oxazinochinolone zur behandlung von viralen infektionen
DE69834937D1 (de) Antibiotika zur behandlung von magengeschwuren
NO984432D0 (no) FremgangsmÕte for behandling av migrenesmerte
DE69737088D1 (de) Therapeutisches agens zur behandlung von fiv infektionen
DE69308762D1 (de) Behandlung des Muskulschwunds
NO982562D0 (no) Sammensetning for behandling av smerte
ATE218866T1 (de) Kombinationstherapie zur behandlung von aids
ATE235494T1 (de) Imino-aza-anthracyclonderivate zur behandlung von amyloidosis
DE69720410D1 (de) Therapeutisches Mittel zur Behandlung hartnäckiger Hundedermatitis

Legal Events

Date Code Title Description
8364 No opposition during term of opposition